POAS (Phaos Technology Holdings Cayman) Equity-to-Asset: -2.72 (As of Oct. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

POAS Phaos Technology Holdings Cayman Ltd POAS
4 GF Score
Price $0.22
! 5 Warning Signs
View Full Analysis

What is Phaos Technology Holdings Cayman Equity-to-Asset?

Phaos Technology Holdings Cayman POAS -6.08% 4 Equity-to-Asset is -2.72 as of Oct. 2025. GuruFocus rates POAS with a GF Score™ of 4/100. The stock has 5 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Phaos Technology Holdings Cayman ranks worse than 97.19% on this metric.

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Phaos Technology Holdings Cayman's Total Stockholders Equity for the quarter that ended in Oct. 2025 was $-2.68 Mil. Phaos Technology Holdings Cayman's Total Assets for the quarter that ended in Oct. 2025 was $0.99 Mil. Therefore, Phaos Technology Holdings Cayman's Equity to Asset Ratio for the quarter that ended in Oct. 2025 was -2.72.

The historical rank and industry rank for Phaos Technology Holdings Cayman's Equity-to-Asset or its related term are showing as below:

POAS' s Equity-to-Asset Range Over the Past 10 Years
Min: -2.72   Med: -1.02   Max: 0.56
Current: -2.72

During the past 3 years, the highest Equity to Asset Ratio of Phaos Technology Holdings Cayman was 0.56. The lowest was -2.72. And the median was -1.02.

POAS's Equity-to-Asset is ranked worse than
97.19% of 853 companies
in the Medical Devices & Instruments industry
Industry Median: 0.65 vs POAS: -2.72

Phaos Technology Holdings Cayman  (AMEX:POAS) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Phaos Technology Holdings Cayman Equity-to-Asset Related Terms


Phaos Technology Holdings Cayman Equity-to-Asset Historical Data

* Premium members only.

The historical data trend for Phaos Technology Holdings Cayman's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phaos Technology Holdings Cayman Equity-to-Asset Chart

Phaos Technology Holdings Cayman Annual Data
Trend Apr23 Apr24 Apr25
Equity-to-Asset
-2.18 0.56 -1.02

Phaos Technology Holdings Cayman Semi-Annual Data
Apr23 Oct23 Apr24 Oct24 Apr25 Oct25
Equity-to-Asset Get a 7-Day Free Trial 0.00 0.56 0.38 -1.02 -2.72

POAS vs WOK, ITOC, INBS: Equity-to-Asset Comparison

For the Medical Devices subindustry, Phaos Technology Holdings Cayman's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Phaos Technology Holdings Cayman Equity-to-Asset vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Phaos Technology Holdings Cayman's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Phaos Technology Holdings Cayman's Equity-to-Asset falls into.


POAS
4GF Score
Phaos Technology Holdings Cayman Ltd POAS
Equity-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Phaos Technology Holdings Cayman Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Phaos Technology Holdings Cayman's Equity to Asset Ratio for the fiscal year that ended in Apr. 2025 is calculated as

Equity to Asset (A: Apr. 2025 )=Total Stockholders Equity/Total Assets
=-1.484/1.462
=-1.02

Phaos Technology Holdings Cayman's Equity to Asset Ratio for the quarter that ended in Oct. 2025 is calculated as

Equity to Asset (Q: Oct. 2025 )=Total Stockholders Equity/Total Assets
=-2.681/0.987
=-2.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Equity-to-Asset →
What does a Equity-to-Asset of -2.72 mean?
Phaos Technology Holdings Cayman (POAS) has a Equity-to-Asset of -2.72 as of Oct. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Phaos Technology Holdings Cayman and its competitors. According to the industry distribution chart, Phaos Technology Holdings Cayman ranks #829 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 97.2%.
Is Phaos Technology Holdings Cayman's Equity-to-Asset too high?
Phaos Technology Holdings Cayman's current Equity-to-Asset is -2.72. Based on the distribution chart, Phaos Technology Holdings Cayman ranks #829 out of 853 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Phaos Technology Holdings Cayman has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Phaos Technology Holdings Cayman's Equity-to-Asset compare to WOK and ITOC?
According to the Medical Devices & Instruments industry distribution chart, Phaos Technology Holdings Cayman ranks #829 out of 853 companies for Equity-to-Asset. This places Phaos Technology Holdings Cayman in the lower half of its industry. The industry median Equity-to-Asset is 0.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.65, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Phaos Technology Holdings Cayman and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phaos Technology Holdings Cayman's current Equity-to-Asset is -2.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phaos Technology Holdings Cayman stock overvalued right now?
Phaos Technology Holdings Cayman (POAS) has a current Equity-to-Asset of -2.72. The current Equity-to-Asset is -2.72. Phaos Technology Holdings Cayman's overall GF Score™ is 4/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Phaos Technology Holdings Cayman (POAS), the current Equity-to-Asset is -2.72 as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Phaos Technology Holdings Cayman Business Description

Address 83 Science Park Drive, 02-01 & 04-01A/B The Curie, Singapore Science Park 1, Singapore, SGP, 118258
Phaos Technology Holdings Cayman Ltd is an investment holding company incorporated in the Cayman Islands. Through its subsidiaries, the Company engages in the research, development, manufacturing, and commercialization of advanced optical technologies and products. Leveraging its patented microsphere technology, Phaos enhances the magnification of traditional optical microscopes, enabling visualization beyond the 200nm optical limit at a commercially viable working distance. The Company offers advanced microscopy equipment and parts, along with AI-powered software solutions that complement its hardware to deliver fully integrated microscopy systems. Its technologies serve diverse sectors, including manufacturing, biomedical, and research.
4GF Score

Get the complete analysis for POAS

Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.22
Price